HI
ANIK icon

Harbour Investments’s Anika Therapeutics ANIK Stock Holding History

Harbour Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9K Buy
+200
New +$2.32K ﹤0.01% 3788
2021
Q4 		– Sell
-200
Closed -$9K – 2650
2021
Q3 		$9K Hold
200
– – ﹤0.01% 2702
2021
Q2 		$9K Hold
200
– – ﹤0.01% 2779
2021
Q1 		$8K Buy
+200
New +$7.59K ﹤0.01% 2697

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Harbour Investments's ANIK Position: Q1 2026 in Review

Harbour Investments opened a new position in Anika Therapeutics (ANIK) in Q1 2026: 200 shares worth $2.9K. The stake represents ﹤0.01% of the portfolio and ranks #3788 among its holdings. This is a return to the name: Harbour Investments previously reported a position in ANIK as recently as Q3 2021.

Harbour Investments first reported a position in ANIK in Q1 2021 and has held it in 4 quarters since. The position peaked at $9K in Q3 2021. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Harbour Investments held 200 shares of Anika Therapeutics worth $2.9K as of Q1 2026.
  • Anika Therapeutics was a new Harbour Investments position in Q1 2026.
  • Anika Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3788 holding.
  • Harbour Investments first reported a position in Anika Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • Harbour Investments's Anika Therapeutics position peaked at $9K in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.